Panacea Index Logo

Command Palette

Search for a command to run...

The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment.

Addiction biology
July 1, 2019
Amir Ghaderi et al. (11 authors)
Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Extracted Claims (11)
InterventionDirectionEndpointPopulationDosageImpactClaim #
melatonin supplementation
decrease
Pittsburgh Sleep Quality Index
patients under methadone maintenance treatment (MMT)
β -4.08; 95 percent CI, -5.51, -2.65; P < 0.001
significantly decreased
#1
melatonin supplementation
decrease
Beck Depression Inventory index
patients under methadone maintenance treatment (MMT)
β -5.46; 95% CI, -8.92, -2.00; P = 0.003
significantly decreased
#2
melatonin supplementation
decrease
Beck Anxiety Inventory index
patients under methadone maintenance treatment (MMT)
β -3.87; 95% CI, -5.96, -1.77; P = 0.001
significantly decreased
#3
melatonin supplementation
increase
International Index of Erectile Functions
patients under methadone maintenance treatment (MMT)
β 5.59; 95% CI, 1.76, 9.42; P = 0.005
significantly increased
#4
melatonin supplementation
decrease
serum insulin levels
patients under methadone maintenance treatment (MMT)
β -2.53; 95% CI, -4.48, -0.59; P = 0.01
had significantly lower
#5
melatonin supplementation
decrease
homeostasis model of assessment-insulin resistance
patients under methadone maintenance treatment (MMT)
β -0.56; 95% CI, -1.03, -0.09; P = 0.01
had significantly lower
#6
melatonin supplementation
increase
quantitative insulin sensitivity check index
patients under methadone maintenance treatment (MMT)
β 0.01; 95% CI, 0.004, 0.02; P = 0.009
higher
#7
melatonin supplementation
increase
HDL-cholesterol levels
patients under methadone maintenance treatment (MMT)
β 3.71; 95% CI, 1.77, 5.64; P = 0.002
higher
#8
melatonin intake
decrease
serum high sensitivity C-reactive protein
patients under methadone maintenance treatment (MMT)
β -0.15; 95% CI, -0.27, -0.02; P = 0.02
significant reduction in
#9
melatonin intake
decrease
malondialdehyde
patients under methadone maintenance treatment (MMT)
β -0.31; 95% CI, -0.57, -0.05; P = 0.02
significant reduction in
#10
melatonin intake
decrease
protein carbonyl
patients under methadone maintenance treatment (MMT)
β -0.06; 95% CI, -0.09, -0.04; P < 0.001
significant reduction in
#11
Abstract

This investigation was designed to determine the effect of melatonin supplementation on mental health parameters, metabolic and genetic profiles in patients under methadone maintenance treatment (MMT). This randomized, double-blind, placebo-controlled, clinical trial was conducted among 54 patients under MMT. Participants were randomly allocated to receive either 10 mg melatonin (2 melatonin capsules, 5 mg each) (n = 26) or placebo (n = 28) once a day, 1 hour before bedtime for 12 weeks. Melatonin supplementation significantly decreased Pittsburgh Sleep Quality Index (β -4.08; 95 percent CI, -5.51, -2.65; P < 0.001), Beck Depression Inventory index (β -5.46; 95% CI, -8.92, -2.00; P = 0.003) and Beck Anxiety Inventory index (β -3.87; 95% CI, -5.96, -1.77; P = 0.001) and significantly increased International Index of Erectile Functions (β 5.59; 95% CI, 1.76, 9.42; P = 0.005) compared with the placebo. Subjects who received melatonin supplements had significantly lower serum insulin levels (β -2.53; 95% CI, -4.48, -0.59; P = 0.01), homeostasis model of assessment-insulin resistance (β -0.56; 95% CI, -1.03, -0.09; P = 0.01) and higher quantitative insulin sensitivity check index (β 0.01; 95% CI, 0.004, 0.02; P = 0.009) and HDL-cholesterol levels (β 3.71; 95% CI, 1.77, 5.64; P = 0.002) compared to placebo. Additionally, melatonin intake resulted in a significant reduction in serum high sensitivity C-reactive protein (β -0.15; 95% CI, -0.27, -0.02; P = 0.02), malondialdehyde (β -0.31; 95% CI, -0.57, -0.05; P = 0.02) and protein carbonyl (β -0.06; 95% CI, -0.09, -0.04; P < 0.001). This trial indicated that taking melatonin supplements for 12 weeks by patients under MMT had beneficial effects on their mental health metabolic profiles.

Medical Subject Headings (MeSH)
AdultAnalgesics, OpioidAntioxidantsAnxietyBlood GlucoseC-Reactive ProteinCholesterol, HDLCholesterol, LDLCholesterol, VLDLDepressionDouble-Blind MethodGene ExpressionGlutathioneHumansInsulin ResistanceInterleukin-1MaleMalondialdehydeMelatoninMental HealthMethadoneMiddle AgedNitric OxideOpiate Substitution TreatmentOpioid-Related DisordersPPAR gammaPenile ErectionRNA, MessengerReverse Transcriptase Polymerase Chain ReactionSleepTransforming Growth Factor betaTriglyceridesTumor Necrosis Factor-alpha
Study Links
Citation Metrics
Total Citations35
Citations/Year5.8
Relative Citation Ratio2.59
NIH Percentile81.6%
Research Impact Scores
APT Score0.75
Related Supplements